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Abstract
Background: The distinction of type 1 and type 2 myocar-
dial infarction (MI) is of major clinical importance. Our 
aim was to evaluate the diagnostic ability of absolute and 
relative conventional cardiac troponin I (cTnI) and high-
sensitivity cardiac troponin T (hs-cTnT) in the distinction 
between type 1 and type 2 MI in patients presenting at the 
emergency department with non-ST-segment elevation 
acute chest pain within the first 12 h.
Methods: We measured cTnI (Dimension Vista) and 
hs-cTnT (Cobas e601) concentrations at presentation and 
after 4 h in 200 patients presenting with suspected acute 
MI. The final diagnosis, based on standard criteria, was 
adjudicated by two independent cardiologists.
Results: One hundred and twenty-five patients (62.5%)
were classified as type 1 MI and 75 (37.5%) were type 2 MI. 
In a multivariable setting, age (relative risk [RR] = 1.43, 
p = 0.040), male gender (RR = 2.22, p = 0.040), T-wave 
inversion (RR = 8.51, p < 0.001), ST-segment depression 
(RR = 8.71, p < 0.001) and absolute delta hs-cTnT (RR = 2.10, 
p = 0.022) were independently associated with type 1 MI. 
In a receiver operating characteristic curve analysis, the 
discriminatory power of absolute delta cTnI and hs-cTnT 
was significantly higher compared to relative c-TnI and 
hs-cTnT changes. The additive information provided by 
cTnI and hs-cTnT over and above the information pro-
vided by the “clinical” model was only marginal.
Conclusions: The diagnostic information provided by 
serial measurements of conventional or hs-cTnT is not bet-
ter than that yielded by a simple clinical scoring model. 
Absolute changes are more informative than relative tro-
ponin changes.
Keywords: cardiac troponin; clinical scores; differential 
diagnosis; myocardial infarction.
Introduction
Chest pain is one of the leading causes of emergency 
department (ED) visits. Patients with chest pain sugges-
tive of acute coronary syndrome (ACS) account for up to 
10% of all ED admissions [1]. The measurement of cardiac 
troponin (cTn) concentrations represents a crucial tool for 
the assessment of patients attending ED units with acute 
chest pain [2]. High-sensitivity (hs) assays allow the meas-
urements of cTn at significantly lower levels with smaller 
degrees of imprecision, which enables them to detect injury 
earlier and further allow measurements of delta change 
(called “delta cTn”) across smaller time intervals [3]. 
Moreover, it has been pointed out that these hs-cTn assays 
reduce the number of false-positive diagnoses by removing 
the element of analytical noise around the discriminant 
limit [4]. However, these hs-cTn assays might appear less 
“specific” for a final diagnosis of acute myocardial infarc-
tion (MI) due to the fact that they identify more cases of 
myocardial injury compared to other conventional or rel-
atively insensitive assays. This issue can lead to a higher 
rate of invasive procedures without necessarily improving 
patient management or outcome [5]. Recent studies have 
reported that different high-sensitivity cardiac troponin T 
(hs-cTnT) assays show poor correlation and concordance, 
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thus emphasizing the importance of temporal troponin 
changes or kinetics [6]. At least theoretically, the release of 
cTn during acute myocardial damage depicts a distinctive 
pattern of rise and fall. The assessment of this pattern as 
diagnostic of type 1 acute MI might improve the specificity.
The latest universal definition of MI introduced the 
term “type 2 MI”, which encompasses cases of acute 
ischemic myocardial injury that develops in the absence of 
complicated atheromatous plaques [7]. Currently, contro-
versy exists as to the definition of type 2 MI [8] and – very 
importantly – regarding the distinction between type 1 and 
type 2 MI. The latter may have important clinical implica-
tions. Two recent studies reported that the performance of 
absolute delta changes in cTn was significantly superior to 
the assessment of relative delta changes for both cardiac 
troponin I (cTnI) and hs-cTnT [9, 10]. However, these two 
studies have limitations in that patient selection may 
have implications regarding the diagnostic performance 
of both cTnI and hs-cTnT, as well as relative and absolute 
delta kinetics. Further, in 2013, Saaby et al. [11] developed 
a new and specific clinical standard for the diagnosis of 
type 2 MI. To the best of our knowledge, the impact of this 
new definition on the diagnostic performance of the kinet-
ics of cTn has never been investigated before.
The aim of the present study was to evaluate the diag-
nostic ability of delta conventional cTnI and hs-cTnT in 
the distinction between type 1 and type 2 MI, as defined by 
Saaby et al. [11] in patients presenting to the ED with non-ST 
segment elevation acute chest pain within the first 12 h.
Materials and methods
Study population
From 1 January to 31 March 2015, we enrolled consecutive patients pre-
senting to the ED of a tertiary referral hospital with chest pain ≤12 h 
and without ST-segment elevation, in whom we measured cTnI at pres-
entation and at 3–6 h, who had at least one result of cTnI above the 
99th percentile. Exclusion criteria were (1) patients with cardiac arrest, 
(2) patients presenting with non-ischemic clinical conditions known 
to be associated with high troponin levels, (3) patients with end-stage 
renal disease, (4) patients presenting with new or presumably new left 
bundle branch block and (5) those who did not meet diagnostic criteria 
for type 1 MI or type 2 MI. The study was performed according to the 
Declaration of Helsinki and approved by the Local Ethics Committee.
Definitions and adjudication of final diagnosis. 
 Definition of type 2 MI
All index diagnoses were independently adjudicated by two clini-
cians. A diagnosis of type 1 MI was made in presence of a clinical 
context suggestive of acute ischemia and cTnI elevation above the 
99th percentile without a plausible alternative cause (i.e. suggestive 
of type 2 MI) [7]. A diagnosis of type 2 MI was made in the presence 
of conditions reflecting an imbalance between myocardial oxygen 
supply and demand, according to the current standard definition 
[11]. Conditions with decreased oxygen supply were severe anemia 
(hemoglobin <8.9 g/L for men and <8.1 g/L for women), shock (sep-
tic, cardiogenic, hypovolemic) defined as systolic blood pressure 
<90  mmHg together with signs of organ dysfunction or encepha-
lopathy, bradyarrhythmias requiring medical treatment or cardiac 
pacing, coronary embolus in the presence of an increased risk of 
embolism or respiratory failure with oxygen tension <60  mmHg 
and clinical signs of acute respiratory failure lasting ≥20  min [11], 
whereas conditions with increased oxygen demand were ventricular 
tachyarrhythmia lasting ≥20 min, supraventricular tachyarrhythmia 
>150 beats/min lasting ≥20 min and hypertensive pulmonary edema 
or arterial hypertension with systolic blood pressure >160 mmHg and 
concomitant left ventricular hypertrophy by electrocardiogram or 
echocardiogram [11].
ST-segment depression was defined as a deviation ≥1 mm in at 
least two leads. Obstructive coronary artery stenoses were defined as 
coronary diameter reductions ≥70% as assessed by quantitative coro-
nary arteriography.
Blood samples and laboratory methods
Blood samples were collected in tubes containing serum separa-
tor at presentation to the ED and 3–6  h later. After centrifugation, 
serum cTnI and hs-TnT were immediately measured. Serum cTnI 
was measured by a contemporary assay in a Dimension Vista ana-
lyzer (Siemens Healthcare Diagnostic, Los Angeles, CA, USA), by a 
chemiluminescent assay (LOCI technology). According to manu-
facturer’s data, limit of detection, 10% coefficient of variation and 
99th percentile of a healthy population were 15 ng/L, 40 ng/L and 
45 ng/L, respectively. Serum cTnT was measured by a high-sensitivity 
assay in a Modular Analytics Cobas e 601 (Roche Diagnostics, Man-
nheim, Germany), by an electrochemiluminescent assay. According 
to manufacturer data, limit of blank, limit of detection, 10% coeffi-
cient of variation and 99th percentile of a healthy population were 3 
ng/L, 5 ng/L, 13 ng/L and 14 ng/L, respectively. We did not use age or 
gender-specific 99th percentile cutoffs, as in routine practice in our 
institution.
For clinical decision-making purposes, only cTnI measurements 
were considered (hs-cTnT were blinded). We calculated “absolute 
delta” as the difference between the second and the first cTn meas-
urements. “Relative delta” was calculated as the ratio (second  minus 
first determination)/first determination, expressed as a percent-
age. In patients with first hs-cTnT measurements showing concen-
trations above the upper reference limit, the value of relative delta 
cTnT > 20% [12] in the diagnosis of type 1 MI was further investigated.
Clinical model
Clinical variables and the value of the relative and absolute delta 
of cTnI and hs-cTnT were analyzed through adjusted binary logis-
tic regression models, in which type 1 MI is the dependent vari-
able. Variables entered in the multivariable model were age, gender, 
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hypertension, type 2 diabetes mellitus, dyslipidemia, current smok-
ing, previous ischemic heart disease, T-wave inversion and ST-
segment depression. We used Mallows’s Cp statistic to select the 
best multivariable model, as an equivalent to the Akaike informa-
tion criterion, to keep a trade-off between the goodness of fit and 
the complexity of the model. To test for consistency of the model, 
we further performed a backward elimination multivariable binary 
logistic regression model by means of likelihood ratio statistic. Dis-
criminative ability and calibration of the multivariable model were 
assessed by the C statistic and Hosmer-Lemeshow, respectively. The 
relative importance of each of the variables retained in the model 
was assessed with the χ2 statistic. We obtained the relative risk (RR) 
and the corresponding 95% confidence intervals (CI) for each of the 
covariates by means of a bootstrapp method with 3000 iterations. 
Age, gender, T-wave inversion and ST-segment depression were con-
sistently shown to be independent predictors of type 1 MI both by 
Mallows’s Cp statistic and backward elimination methods, conse-
quently being included in the final model with the purpose of the 
statistical analyses (named henceforth “clinical model”).
Statistical analysis
Continuous variables were presented as medians (with 25th and 
75th percentiles) or means (with standard deviations). Categorical 
variables were expressed as frequencies and percentages with differ-
ences analyzed with the χ2-test. To evaluate the discrimination ability 
for the diagnosis of type 1 MI of delta cTnI and hs-cTnT individually 
and above that of the clinical model, we estimated the area under 
the curve (AUC) of the receiver operating characteristic (ROC) curves. 
The Delong method [13] was used to compare the AUC. We addition-
ally estimated the optimal ROC curve-derived cutoffs by Zweig and 
Campbell [14] method. We used Macro !DT for SPSS Statistics (Diag-
nostic Tests [computer program], Universitat Autònoma de Barce-
lona) to evaluate the diagnostic performance of relative cTnT ≥20% 
for the diagnosis of type 1 MI in comparison with the optimal cutoffs 
for absolute cTnI and cTnT. Software packages SPSS 21.0 (SPSS Inc., 
Chicago, IL, USA) and Stata 12 (Stata Corp., College Station, TX, USA) 
were used for the statistical analyses. In all tests, a two-sided p-value 
0.05 was considered significant.
Results
Baseline characteristics
Two hundred and sixty-one consecutive patients pre-
sented to the ED with acute chest pain ≤12 h who received 
Table 1: Baseline characteristics by type of myocardial infarction.
Total cohort n = 200 Type 1 MI n = 125 (62.5%) Type 2 MI n = 75 (37.5%) p-Value
Age, years 69.8 ± 15.5 70.9 ±13.4 67.9 ± 18.5 0.174
Male gender, n (%) 134 (67.0) 90 (72.0) 44 (58.7) 0.052
Risk factors
 Previous ischemic heart disease, n (%) 99 (49.5) 69 (55.2) 30 (40.0) 0.037
 Diabetes mellitus, n (%) 88 (44.0) 59 (47.2) 29 (38.7) 0.239
 Hypertension, n (%) 145 (72.5) 91 (72.8) 54 (72.0) 0.902
 Dyslipidemia, n (%) 104 (52.0) 66 (52.8) 38 (50.7) 0.770
 Active smoking, n (%) 37 (18.5) 27 (21.6) 10 (13.3) 0.145
Presentation and in-hospital management
 Chest pain <6 h, n (%) 164 (82.0) 102 (81.6) 62 (82.7) 0.849
 ST-segment depression, n (%) 50 (25.0) 43 (34.4) 7 (9.3) <0.001
 T-wave inversion, n (%) 54 (27.0) 45 (36.0) 9 (12.0) <0.001
 Cardiac catheterization, n (%) 103 (51.5) 91 (72.8) 12 (16.0) <0.001
 Presence of coronary stenoses ≥70%, n (%) 86 (83.5) 82 (90.1) 4 (33.3) <0.001
 Number of diseased vessels 1.5 ± 1.1 1.7 ± 1.0 0.7 ± 1.2 0.014
 Number of stents implanted 1.3 ± 1.4 1.5 ± 1.4 0.3 ± 0.8 <0.001
Contemporary conventional cardiac troponin I (Siemens Dimension Vista)
 First blood draw, ng/mL 0.094 (0.044–0.359) 0.149 (0.053–0.552) 0.069 (0.041–0.167) 0.003
 Second blood draw, ng/mL 0.665 (0.123–2.225) 1.450 (0.228–2.935) 0.199 (0.076–0.724) <0.001
 Absolute delta, ng/mL 1.89 ± 4.38 2.63 ± 5.19 0.64 ± 2.00 <0.001
 Relative delta, % 1620 ± 4672 2088 ± 5616 840 ± 2205 0.028
High-sensitivity cardiac troponin T (Roche Elecsys)
 First blood draw, ng/L 41 (22–78) 45 (24–93) 33 (20–58) 0.009
 Second blood draw, ng/L 108 (39–271) 171 (53–319) 49 (34–126) <0.001
 Absolute delta, ng/L 134 ± 250 182 ± 295 53 ± 108 <0.001
 Relative delta, % 318 ± 702 404 ± 831 174 ± 368 0.008
Time interval between determinations, h 4.4 ± 1.0 4.4 ± 1.0 4.3 ± 1.0 0.670
MI, acute myocardial infarction. Cardiac troponins are expressed as median (25th percentile–75th percentile).
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a first determination of cTnI on presentation and a second 
measurement within 3–6 h, with at least one result of cTnI 
above the 99th percentile. Sixty-one patients presenting 
with ST-segment elevation or new/presumably new left 
bundle branch block were excluded. In the present study, 
we finally included 200 patients of which 125 (62.5%) 
were classified as type 1 MI and 75 (37.5%) were type 2 MI. 
Final diagnoses of patients with type 2 MI were as follows: 
tachyarrhythmia (40.5%), severe systemic hyperten-
sion (21.6%), sepsis (18.9%), anemia (9.5%) and respira-
tory failure (9.5%). A total of 147 (73.5%) and 181 (90.5%) 
showed raised levels on the first measurement of cTnI and 
hs-cTnT, respectively.
Mean time interval between determinations of cTn 
was 4.4  h (95% CI 3.4–5.4). Baseline characteristics of 
the study population are shown in Table 1. Baseline and 
serial cTns levels according to adjudicated diagnosis are 
shown in Figure 1. Patients with a final diagnosis of type 
1 MI were predominantly male, showed significantly more 
previous ischemic heart disease, T-wave inversion and ST-
segment depression, underwent more cardiac catheteriza-
tion procedures and coronary stenting and showed a more 
extensive coronary disease.
Patients with type 1 MI showed significantly higher 
cTnI levels obtained at the second blood draw and both 
absolute and relative delta cTnI values as compared to 
those with type 2 MI. Regarding hs-cTnT, we observed 
significantly higher levels both at first and second blood 
draw, as well as absolute and relative delta values (Table 1).
Predictors of type 1 MI
In a multivariable regression model, age (RR per stand-
ard deviation = 1.43, p = 0.040, χ2 = 1.86), male gender 
(RR = 2.22, p = 0.040, χ2 = 3.77), T-wave inversion (RR = 8.51, 
p < 0.001, χ2 = 13.70) and ST-segment depression (RR = 8.71, 
p < 0.001, χ2 = 15.71) were independently associated 
with type 1 MI (Table 2). Higher absolute delta hs-cTnT 
values were also independently associated with type 1 MI 
(RR = 2.10, p = 0.022, χ2 = 12.53, Table 2).
Diagnostic performance of the clinical model 
and delta cardiac troponins
The clinical model showed a discrimination capacity 
(shown in Figure 2) equal to (AUC) 0.810 (95% CI 0.749–
0.871). Neither absolute delta nor relative delta of c-TnI 
and hs-TnT significantly improved the discrimination 
or calibration above the clinical model, as shown in 
Figure 2.
We further analyzed the discrimination capacity 
of the absolute and relative delta cTnI/hs-cTnT in com-
parison with the clinical model. The AUC of the clinical 
model (0.810, 95% CI 0.749–0.871) was higher compared 
to both absolute (0.720, 95% CI 0.648–0.792, p = 0.088) 
and relative cTnI (0.647, 95% CI 0.568–0.725, p = 0.002). 
The same observation was true when the comparator 
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Figure 1: Patients with type 1 MI showed significantly higher cTnI and hs-cTnT levels obtained at the second blood drawn.
Baseline and serial conventional (A) and high-sensitivity (B) cardiac troponins according to adjudicated diagnosis (type 1 or type 
2  myocardial infarction).
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was hs-cTnT (absolute delta, 0.689, 95% CI 0.615–0.763, 
p = 0.020; relative delta, 0.646, 95% CI 0.567–0.724, 
p = 0.001). Further, the AUC values of absolute delta 
cTnI and hs-cTnT were significantly higher compared to 
relative c-TnI and hs-TnT deltas (p = 0.001 and p = 0.011, 
respectively). Finally, the AUC corresponding to abso-
lute delta cTnI showed a trend to be superior compared 
to hs-cTnT (p = 0.064). When we restricted analyses only 
to those patients with type 1 MI and significant coronary 
disease observed during angiography, the results were 
consistent with the overall findings.
Diagnostic performance of relative delta cTnT 
>20% for the diagnosis of type 1 MI
We examined the diagnostic performance of relative delta 
hs-cTnT >20% in patients with first determination of 
hs-TnT levels above the upper reference limit (>14 ng/L), 
and this information is presented in Table 3. The positive 
predictive value was 72.9% (95% CI 64.2–80.1), the nega-
tive predictive value was 52.5% (95% CI 40.4–64.5) and 
overall efficiency was 65.9% (95% CI 58.7–72.5).
Discussion
The discrimination between type 1 and type 2 MI is of 
paramount importance. Patients diagnosed with type 1 MI 
are treated with medication and invasive procedures that 
have shown to increase survival [15, 16]. However those 
with type 2 MI entail an adverse outcome [17], and so far 
we do not have therapeutic strategies aimed at treating 
specifically the myocardial necrosis and improving their 
prognosis besides those procedures treating the underly-
ing disease. The present study shows, first, the informa-
tion provided by serial measurements (delta) of both cTnI 
and hs-cTnT is lower compared to that yielded by a simple 
clinical model comprising age, gender and electrocardio-
graphic findings in the diagnosis of type 1 MI compared 
to type 2 MI. Second, the additive information provided 
by both conventional and hs-cTn above the clinical model 
is marginal, if any. Third, the discrimination of absolute 
delta cTnI and hs-cTn is significantly higher compared 
to the relative values, but no significant differences were 
found among them. Finally, the diagnostic performance 
of hs-cTnT >20% in the diagnosis of type 1 MI seems to be 
limited, given the observed moderate positive and nega-
tive predictive values.
Table 2: Logistic regression model: predictors of type 1 myocardial infarction.
Bivariate Multivariate
Relative risk 95% CI Relative riska 95% CI
Age, yearsb 1.22 0.92–1.61 1.43 1.01–2.03
Male gender 1.81 0.99–3.31 2.22 1.07–4.59
Previous ischemic heart disease 1.85 1.03–3.31 – –
Diabetes mellitus 1.42 0.79–2.54 – –
Hypertension 1.04 0.55–1.97 – –
Dyslipidemia 1.09 0.61–1.93 – –
Active smoking 1.79 0.81–3.95 – –
ST-segment depression 5.09 2.15–12.1 8.71 3.50–21.6
T-wave abnormalities 4.13 1.88–9.06 8.51 3.61–20.1
Contemporary conventional cardiac troponin I (Siemens Dimension Vista)
 First blood draw, ng/mLb 1.38 0.87–2.20 1.29 0.78–2.12
 Second blood draw, ng/mLb 3.51 1.43–8.64 2.06 1.01–4.19
 Absolute delta, ng/mLb 3.67 1.42–9.51 2.04 0.99–4.17
 Relative delta, %b 1.77 0.93–3.37 1.26 0.67–2.36
High-sensitivity cardiac troponin T (Roche Elecsys)
 First blood draw, ng/Lb 1.70 1.01–2.84 1.46 0.86–2.49
 Second blood draw, ng/Lb 3.54 1.79–7.00 2.24 1.20–4.21
 Absolute delta, ng/Lb 3.33 1.65–6.70 2.10 1.11–3.97
 Relative delta, %b 1.90 1.07–3.37 1.43 0.87–2.34
MI, acute myocardial infarction; CI, confidence interval. aAdjusted by age, gender, type 2 diabetes mellitus, current smoking, hyperten-
sion, dyslipidemia, ST-segment depression and T-wave abnormalities. bIt represents the relative risk per standard deviation. The “clinical 
model” comprises age, gender, T-wave inversion and ST-segment depression. C-Statistic (Clinical Model) = 0.81, Mallows’s Cp (Clinical 
Model) = 4.61, Hosmer-Lemeshow p-value (Clinical Model) = 0.85, −2 log-likelihood (Clinical Model) = 211.
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Table 3: Diagnostic performance of relative delta high-sensitivity cardiac troponin T > 20%, absolute delta cardiac troponin T > 32.9 ng/L 
and absolute delta cardiac troponin I > 0.02 ng/mL for the diagnosis of type 1 myocardial infarction (vs. type 2 myocardial infarction).
 
 
Relative delta cTnT 
>20%
 
 
Absolute delta cTnT 
>32.9 ng/L
 
 
Absolute delta cTnI 
>0.02 ng/mL
Value  95% CI Value  95% CI Value  95% CI
Sensitivity, %   74.8  66.1–81.8  63.2  54.5–71.1  85.6  78.4–90.7
Specificity, %   50.0  38.1–61.9  73.3  62.4–82.0  40.0  29.7–51.3
False positives, %   50.0  38.1–61.9  26.7  18.0–37.6  60.0  48.7–70.4
False negatives, %   25.2  18.2–33.9  36.8  28.9–45.5  14.4  9.3–21.6
Positive likelihood ratio   1.5  –  2.4  –  1.4  –
Negative likelihood ratio   0.5  –  0.5  –  0.4  –
Positive predictive value, %   72.9  64.2–80.1  79.8  70.8–86.5  70.4  62.7–77.1
Negative predictive value, %  52.5  40.2–64.5  54.5  44.7–63.8  62.5  48.4–74.8
Efficiency, %   65.9  58.7–72.5  67.0  60.2–73.1  68.5  61.8–74.5
Absolute delta cTnT > 32.9 ng/L and absolute delta cTnI > 0.02 ng/mL are optimal ROC-curve based cutoffs obtained by Zweig and Campbell 
[14] method.
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AUC, area under the curve; CI, confidence interval; hs, high sensitivity. The clinical model comprises age, gender,
T-wave inversion and ST-segment depression.
Figure 2: Additive discrimination above the clinical model of the relative and absolute delta cardiac troponins.
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The technical refinement of laboratory troponin has 
led a progressive increase in the proportion of patients 
with elevated troponin levels presenting with a variety 
of clinical conditions other than ACS [12]. Thus, for cli-
nicians, it represents a tough challenge to differentiate 
between patients with type 1 acute MI versus those having 
acute myocardial necrosis with a different non-ischemic 
underlying disease. Both the Joint European Society of 
Cardiology/American College of Cardiology Foundation/
American Heart Association/World Heart Federation task 
force for the Universal definition of MI and the National 
Academy of Clinical Biochemistry recommend a 20% 
change from an elevated cTn value as indicative of addi-
tional myocardial necrosis [18]. This 20% represents a 
significant (>3 standard deviations of the variation associ-
ated with an elevated baseline concentration) change in 
cTn based on a 5%–7% analytic total coefficient of vari-
ation. Because this criterion was derived from the use of 
contemporary cTn assays, studies have reexamined the 
best metrics for change [9, 10]. Evidence from two large 
observational studies has suggested that absolute changes 
in hs-cTnT may have significantly higher diagnostic accu-
racy for acute MI than relative changes [9, 10]. Other 
experts have, however, suggested using a combination 
of absolute and relative changes as the best option [19]. 
The position paper by the Study Group on Biomarkers in 
Cardiology of the European Society of Cardiology Working 
Group on Acute Cardiac Care recommended using an 
absolute change for baseline levels below the 99th per-
centile and a relative change of 20% for baseline levels 
above the 99th percentile [2]. In our study, the discrimi-
nation capacity for the diagnosis of type 1 MI of absolute 
delta cTnI and hs-cTnT was significantly higher compared 
to relative delta. Two previous studies reported, consist-
ently with our results, that the performance of absolute 
delta changes were significantly superior to the relative 
delta changes both for cTnI and hs-cTnT [9, 10]. However, 
the AUC values reported by Mueller et al. [9] and Reich-
lin et al. [10] both for relative and absolute contemporary 
cTnI and hs-cTnT were higher as compared to our values. 
We believe that this disparity is related to the selection of 
the population and the choice of the comparator. In the 
studies by Mueller et  al. [9] and Reichlin et  al. [10], the 
reference category was composed of a heterogeneous pop-
ulation of patients with unstable angina, non-ischemic 
cardiac disease and non-cardiac disease. Further, the 
study by Mueller et al. [9] included a significant propor-
tion of patients without chest pain at presentation (≈53%). 
These particularities regarding the selection of patients 
might have implications on the diagnostic performance 
of cTnI and hs-cTnT as well as relative and absolute delta 
kinetics. Thus, we believe that our results are relevant as 
the present study only included patients with confirmed 
type 1 MI and those with type 2, defined by stringent cri-
teria. Despite controversy, we followed the definition by 
Saaby et  al. [11] to classify patients because it afforded 
the most reliable pathophysiological description of this 
clinical entity. Notably, the information provided by 
the clinical model was significantly higher compared to 
both absolute and relative cTnI and hs-cTnT. This finding 
emphasizes, in our view, the concept that the interpreta-
tion of whatever result of a laboratory test (also cTn) must 
be made taking into account the clinical scenario. Particu-
larly in patients with acute chest pain, in which a cause 
has not been clearly found after an initial evaluation, 
careful assessment of the electrocardiogram is crucial for 
a correct final diagnosis. In our study, both T-wave inver-
sion and ST-segment depression showed the highest χ2 
statistic values, thus suggesting that the  information pro-
vided by the assessment of the electrocardiogram was the 
most important for the diagnosis of type 1 MI.
In our study, 25.2% of all patients with a final diagno-
sis of non ST-segment elevation MI (and a first cTn deter-
mination above the upper reference limit) presented with 
relative delta hs-cTnT <20%. This finding is not unique in 
our study [10], and it can be speculated that this group of 
patients might have reached a plateau of the cTn release 
curve, probably in small MIs. Moreover, 50% of patients 
with type 2 MI and first hs-cTnT above the reference limit 
presented a relative delta hs-cTnT >20%. These observa-
tions conditioned that the positive predictive value was 
only 72.9% (95% CI 64.2–80.1), and the negative predictive 
value was poor (52.5%, 95% CI 40.4–64.5).
Limitations
We note several limitations with our current observational 
study. First, given the limited sample size, the present study 
can only be considered as exploratory. Notably, however, 
in our study, the relative proportion of type 1 MI/type 2 MI 
(62.5/37.5 vs. 65.9/34.1%) was consistent that reported by 
a recent manuscript [17] in a bigger contemporary sample 
(n = 1010). However, we observed a different prevalence of 
causes for type 2 MI in our study in comparison with previous 
studies [11, 17]. Whether the findings of the present investiga-
tion are applicable to other hospitals warrants larger studies. 
Second, we included patients with acute chest pain of 
unknown origin after initial clinical evaluation by an expe-
rienced physician in the ED. However, the characteristics of 
the episode of chest pain at presentation were not registered 
in our study. Third, the study is observational in nature, so 
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the decision to serially measure troponins was dependent 
on judgment of the physician. Therefore, we did not obtain 
measurements for all patients at fixed time points, and this 
could have led to a selection bias.
Conclusions
In this study, we have shown that the information pro-
vided by delta conventional and hs cTn is marginal in 
comparison with age, gender, T-wave inversion and ST-
segment deviation in the identification of patients with a 
type 1 MI compared to those with type 2 MI. We also show 
that applying more stringent diagnostic criteria, the per-
formance of both delta cTnI and hs-cTnT was moderate.
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